Raymond James & Associates’s iShares US Healthcare ETF IYH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $26.8M | Sell |
413,046
-14,722
| -3% | -$941K | 0.02% | 675 |
|
|
2024
Q2 | $26.2M | Sell |
427,768
-39,707
| -8% | -$2.39M | 0.02% | 649 |
|
|
2024
Q1 | $28.9M | Buy |
467,475
+19,110
| +4% | +$1.15M | 0.02% | 607 |
|
|
2023
Q4 | $25.7M | Sell |
448,365
-41,905
| -9% | -$2.28M | 0.02% | 632 |
|
|
2023
Q3 | $26.5M | Buy |
490,270
+14,155
| +3% | +$791K | 0.02% | 573 |
|
|
2023
Q2 | $26.7M | Sell |
476,115
-26,840
| -5% | -$1.49M | 0.02% | 579 |
|
|
2023
Q1 | $27.5M | Buy |
502,955
+2,995
| +0.6% | +$164K | 0.02% | 556 |
|
|
2022
Q4 | $28.4M | Buy |
499,960
+42,195
| +9% | +$2.33M | 0.03% | 518 |
|
|
2022
Q3 | $23.2M | Buy |
457,765
+33,115
| +8% | +$1.79M | 0.02% | 559 |
|
|
2022
Q2 | $22.8M | Buy |
424,650
+70,835
| +20% | +$3.89M | 0.02% | 574 |
|
|
2022
Q1 | $20.4M | Sell |
353,815
-66,640
| -16% | -$3.72M | 0.02% | 697 |
|
|
2021
Q4 | $25.3M | Buy |
420,455
+90,545
| +27% | +$5.17M | 0.02% | 634 |
|
|
2021
Q3 | $18.2M | Buy |
329,910
+2,565
| +0.8% | +$147K | 0.02% | 762 |
|
|
2021
Q2 | $17.9M | Sell |
327,345
-50,830
| -13% | -$2.69M | 0.02% | 771 |
|
|
2021
Q1 | $19.1M | Buy |
378,175
+50,230
| +15% | +$2.53M | 0.02% | 689 |
|
|
2020
Q4 | $16.1M | Buy |
327,945
+16,750
| +5% | +$791K | 0.02% | 718 |
|
|
2020
Q3 | $14.1M | Sell |
311,195
-64,960
| -17% | -$2.94M | 0.02% | 690 |
|
|
2020
Q2 | $16.2M | Buy |
376,155
+18,815
| +5% | +$794K | 0.02% | 607 |
|
|
2020
Q1 | $13.4M | Buy |
357,340
+9,125
| +3% | +$375K | 0.02% | 614 |
|
|
2019
Q4 | $15M | Buy |
348,215
+15,120
| +5% | +$611K | 0.02% | 704 |
|
|
2019
Q3 | $12.6M | Sell |
333,095
-890
| -0.3% | -$34.3K | 0.02% | 749 |
|
|
2019
Q2 | $13M | Sell |
333,985
-30,965
| -8% | -$1.17M | 0.02% | 725 |
|
|
2019
Q1 | $14.1M | Sell |
364,950
-90,220
| -20% | -$3.43M | 0.02% | 655 |
|
|
2018
Q4 | $16.5M | Buy |
455,170
+178,515
| +65% | +$6.84M | 0.03% | 546 |
|
|
2018
Q3 | $11.2M | Buy |
276,655
+15,155
| +6% | +$585K | 0.02% | 776 |
|
|
2018
Q2 | $9.32M | Sell |
261,500
-4,490
| -2% | -$158K | 0.02% | 850 |
|
|
2018
Q1 | $9.18M | Buy |
265,990
+31,875
| +14% | +$1.15M | 0.02% | 823 |
|
|
2017
Q4 | $8.16M | Buy |
234,115
+78,950
| +51% | +$2.74M | 0.02% | 873 |
|
|
2017
Q3 | $5.33M | Buy |
155,165
+36,490
| +31% | +$1.23M | 0.01% | 1050 |
|
|
2017
Q2 | $3.95M | Buy |
118,675
+490
| +0.4% | +$15.7K | 0.01% | 1147 |
|
|
2017
Q1 | $3.68M | Sell |
118,185
-68,685
| -37% | -$2.1M | 0.01% | 1172 |
|
|
2016
Q4 | $5.39M | Buy |
186,870
+93,665
| +100% | +$2.71M | 0.01% | 951 |
|
|
2016
Q3 | $2.8M | Sell |
93,205
-3,760
| -4% | -$115K | 0.01% | 1268 |
|
|
2016
Q2 | $2.88M | Sell |
96,965
-11,250
| -10% | -$329K | 0.01% | 1129 |
|
|
2016
Q1 | $3.04M | Buy |
108,215
+17,345
| +19% | +$480K | 0.01% | 1071 |
|
|
2015
Q4 | $2.73M | Sell |
90,870
-12,460
| -12% | -$370K | 0.01% | 1092 |
|
|
2015
Q3 | $2.89M | Sell |
103,330
-8,090
| -7% | -$252K | 0.01% | 1020 |
|
|
2015
Q2 | $3.54M | Sell |
111,420
-117,615
| -51% | -$3.7M | 0.01% | 998 |
|
|
2015
Q1 | $7.07M | Buy |
229,035
+170,965
| +294% | +$5.16M | 0.03% | 590 |
|
|
2014
Q4 | $1.67M | Sell |
58,070
-136,810
| -70% | -$3.85M | 0.01% | 1264 |
|
|
2014
Q3 | $5.24M | Buy |
194,880
+67,445
| +53% | +$1.78M | 0.03% | 606 |
|
|
2014
Q2 | $3.27M | Sell |
127,435
-19,230
| -13% | -$475K | 0.02% | 838 |
|
|
2014
Q1 | $3.61M | Buy |
146,665
+37,125
| +34% | +$903K | 0.02% | 710 |
|
|
2013
Q4 | $2.55M | Buy |
+109,540
| New | +$2.46M | 0.02% | 816 |
|
Other funds holding IYH
PCH
Raymond James & Associates's IYH Position: Q3 2024 in Review
Raymond James & Associates reduced its iShares US Healthcare ETF (IYH) stake by 3.4% in Q3 2024, selling an estimated $941K and leaving 413,046 shares worth $26.8M. The position accounts for 0.02% of the portfolio, ranked #675.
Raymond James & Associates first reported a position in IYH in Q4 2013 and has held it in 44 quarters since. The position peaked at $28.9M in Q1 2024. 514 funds tracked by Wall St. Rank hold IYH as of Q3 2024.
- Raymond James & Associates held 413,046 shares of iShares US Healthcare ETF worth $26.8M as of Q3 2024.
- Raymond James & Associates sold 14,722 iShares US Healthcare ETF shares in Q3 2024, an estimated $941K.
- iShares US Healthcare ETF made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #675 holding.
- Raymond James & Associates first reported a position in iShares US Healthcare ETF in Q4 2013 and has held it in 44 quarters since.
- Raymond James & Associates's iShares US Healthcare ETF position peaked at $28.9M in Q1 2024.
- 514 funds tracked by Wall St. Rank held iShares US Healthcare ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.